F Farinati, D Marino, M De Giorgio, A Baldan, … - Am J Gastroenterol, 2006 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 74 - Related articles - BL Direct - All 7 versions
IN Lee, CH Chen, JC Sheu, HS Lee, GT … - Proteomics, 2006 - sapmed.ac.jp Although the significant risk factors for hepatocellular carcinoma (HCC) are
well known from epidemiological studies, diagnosis of this disease at an early
stage is difficult, and HCC remains one of the leading causes of cancer ... Cited by 66 - Related articles - View as HTML - BL Direct - All 5 versions
L Zhou, J Liu, F Luo… - 世界胃肠病学杂志: 英文版, 2006 - wjg.wjgnet.com Hepatocellular carcinoma (HCC) is one of the most frequent malignant tumors and
is the second most common cause of cancer death in China. Therefore, it is very
important to detect this disease and the recurrence at its earlier period. ... Cited by 61 - Related articles - Cached - BL Direct - All 6 versions
A Colli, M Fraquelli, G Casazza, S Massironi, … - American Journal of Gastroenterology, 2006 - med.unc.edu Agostino Colli, MD,1 Mirella Fraquelli, MD, Ph.D.,2 Giovanni Casazza, Ph.D.,3
Sara Massironi, MD,1 Alice Colucci, MD,1 Dario Conte, MD,2 and Piergiorgio Duca,
MD3 1Department of Internal Medicine, Ospedale “A. Manzoni”, Lecco, ... Cited by 62 - Related articles - View as HTML - BL Direct - All 8 versions
JA Talwalkar, GJ Gores - Gastroenterology, 2004 - Elsevier The diagnosis of hepatocellular carcinoma (HCC) includes detection of the index
lesion, staging of the lesion within the liver, and assessment for extrahepatic
metastasis. HCC is a highly vascular neoplasm usually arising in a ... Cited by 59 - Related articles - BL Direct - All 16 versions
DG Ward, Y Cheng, G N'kontchou, TT Thar, N … - British journal of cancer, 2006 - pubmedcentral.nih.gov Early diagnosis of hepatocellular carcinoma (HCC) is the key to the delivery of
effective therapies. The conventional serological diagnostic test, estimation of
serum alpha-fetoprotein (AFP) lacks both sensitivity and specificity as a ... Cited by 53 - Related articles - BL Direct - All 5 versions
MF Yuen, CL Lai - Best Practice & Research Clinical Gastroenterology, 2005 - Elsevier Serological markers for hepatocellular carcinoma (HCC) are important for early
diagnosis, as well as monitoring of tumour aggressiveness, treatment
responsiveness, recurrence and survival. The three most common markers are ... Cited by 55 - Related articles - All 13 versions
OS Lin, EB Keeffe, GD Sanders, DK Owens - Alimentary Pharmacology and Therapeutics, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 46 - Related articles - BL Direct - All 8 versions
- ►cbc.org.br [PDF] JN Cormier, KT Thomas, RS Chari, CW … - Journal of Gastrointestinal Surgery, 2006 - Springer Hepatocellular carcinoma (HCC) is one of the most common tumors globally, with
varying prevalence based on endemic risk factors. In high-risk populations,
including those with hepatitis B or C or with cirrhosis, serum ... Cited by 44 - Related articles - All 6 versions
RB Freeman, EB Edwards, AM Harper - American Journal of Transplantation, 2006 - interscience.wiley.com Equitable liver allocation should ensure that nonelective removal rates are
fairly distributed among waiting candidates. We compared removal rates for
adults entered with nonmalignant (NM) (N = 9379) and hepatocellular cancer ... Cited by 44 - Related articles - BL Direct - All 5 versions
